Is it time to reconsider the lipopolysaccharide paradigm in acute graft-versus-host disease?

HIGHLIGHTS

• who: Philippe Saas from the Université Bourgogne Franche-Comté, EFS Bourgogne Franche-Comté, UMR1098, France, Department of Hematology, University Hospital of, France, LipSTIC LabEx, FHU INCREASE have published the Article: Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?, in the Journal: (JOURNAL)
• what: The reason of this beneficial activity has not been explored so far. The authors propose to reconsider the assumption that LPS/TLR-4 interactions result in a unique agonist pro-inflammatory reaction in GVHD, since heterogeneity of its sources and structures exist.
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.